Does OFATUMUMAB Cause Injection site haemorrhage? 406 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 406 reports of Injection site haemorrhage have been filed in association with OFATUMUMAB (ARZERRA). This represents 1.4% of all adverse event reports for OFATUMUMAB.
406
Reports of Injection site haemorrhage with OFATUMUMAB
1.4%
of all OFATUMUMAB reports
0
Deaths
15
Hospitalizations
How Dangerous Is Injection site haemorrhage From OFATUMUMAB?
Of the 406 reports, 15 (3.7%) required hospitalization, and 2 (0.5%) were considered life-threatening.
Is Injection site haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 406 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Injection site haemorrhage?
ADALIMUMAB (11,715)
EXENATIDE (5,527)
ETANERCEPT (4,674)
TIRZEPATIDE (4,389)
EVOLOCUMAB (3,720)
DULAGLUTIDE (3,028)
TERIPARATIDE (2,330)
GALCANEZUMAB-GNLM (1,415)
DUPILUMAB (1,401)
HUMIRA (1,304)
Which OFATUMUMAB Alternatives Have Lower Injection site haemorrhage Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB